Monday, 22 September 2008

A week of awareness

The MDS supported the annual nation-wide AMD Awareness Week by organising two support group sessions on Saturday.

After receiving a plaque of appreciation from guest of honour Minister Lim Boon Heng, who is in charge of ageing issues in Singapore, MDS got down to work at the Idea Lab of Alexandra Hospital.


MDS president Sharon Siddique hosted a session in English before secretary Peh Shing Huei chaired one in Mandarin together with Exco member Anny Leow. Exco member Sam Fong will also host a session on Wednesday.

This is the second year that MDS is a partner of the AMD Awareness Week.

Sunday, 14 September 2008

Breakthrough lens for the VIPs

A new type of lens can now be inserted into the eye to help severe macular degeneration patients see better - giving much hope to sufferers.

This ground-breaking surgery in Britain is called the IOL VIP (intra-ocular lens for visually impaired people) procedure. It is very similar to a cataract removal, in which the ocular lens is replaced with an artificial one behind the iris.
For IOL VIP (see picture above), a second lens is also placed in front of the iris - creating a slightly magnified image much like a telescope. As a result, light entering the eye is directed to a healthy part of the retina and away from the macular scar, giving patients back some of their useful vision.
The procedure is painless and takes about 20-30 minutes under simple eyedrop anaesthesia. It is easy to carry out and the effects are almost immediate. It was first successfully carried out in March 2007.
Seventy-three-year-old grandmother Mary Johnson is one of the first patients to benefit. She said: "I noticed the difference more or less straightaway. When you have macular degeneration you no longer take your sight for granted, and being able to get out in the garden to pick up the weeds has meant so much to me.
"One day I was walking through town with my husband and I said: 'Look! I can see House of Fraser!' I was so excited that I was able to read the sign. Hopefully, with time, my sight will improve even more. But if I stay as I am now I will be satisfied."
But ophthalmic surgeon Sakkaf Ahmed Aftab, who runs a clinic from Grimsby's St Hugh's Hospital and was one of the first surgeons to be trained in the IOL VIP pointed out the surgery is not suitable for everyone.
It is also not a miracle cure and is only appropriate for patients who have lost a significant level of vision. However, it can restore enough of a patient's sight to drastically improve their quality of life.
"This is a procedure for people who cannot see," he said. "There's no way that after having this you would be able to read small print or start driving again. But that's why this work is so rewarding - because you are giving people back their vision when before they had none at all."
Click here to read the complete article and here to find out more about IOL VIP. See below for a video of how the procedure is carried out.

Tuesday, 9 September 2008

No more injections?

Uncomfortable, intimidating and regular injections into your eye could be a thing of the past if a tiny metal coil succeeds as the new drug dispenser for retinal problems.

The spiral-shaped coil (see below) - which looks just like the children's toy "slinky" - can be injected into the eye using a needle in a minimally invasive procedure that takes just 15 minutes.


After that ONE injection, no more is needed for two years. This is because the drugs are mixed into a material which coats the slinky. As the coating slowly dissolves, the drugs are released over a period of up to two years.

Now, the most effective drugs for macular degeneration patients, such as Lucentis, Avastin and Macugen, are all directly injected into the eyes. The injections often have to be repeated every month, something which patients find uncomfortable.

The new device, which is called I-Vation, is meant to stop this hassle and pain. It is made from a metal alloy. The Slinky is coated with a synthetic material that incorporates the drugs. As the coating breaks down, it releases drug particles into the eye.

The design and thickness of this material can be adjusted so it degrades at the required rate. The spiral shape means there is a large surface area available for the drug coating, allowing the release of drugs for up to two years.

The coiled shape also makes it possible to lodge the device against the white of the eye, without the need for stitches. It will be out of the line of sight of the patient, so it cannot be seen. It can also be easily removed and replaced.

Soon, you may be able to tell your children or grandchildren that you have something like Toy Story's Slinky Dog in your eye!

Please click here to read more.

Sunday, 31 August 2008

From Sam to Sharon

Sharon Siddique has been elected as the new president of the Macular Degeneration Society of Singapore yesterday. The 61-year-old academic, writer and consultant replaces Sam Fong, who has led the society since its founding in June 2007.

Sharon was chosen as the president by a new seven-man executive committee, which was elected by MDS members in its inaugural Annual General Meeting last month.

Journalist Peh Shing Huei, the former treasurer, will take over as secretary - a position which was formerly occupied by Sharon. Lee Soo Mien, a lab technologist, is the new treasurer.

The other Exco members are former Ministry of Community Development deputy secretary Lim Hsiu Mei, nurse Anny Leow, former teacher Doreen Heng and Sam.

Sam, a retired engineer and a glaucoma patient, had asked to step down as president to concentrate on his volunteer work as the head of the Glaucoma Patients Association - a partner of MDS.

The MDS would like to thank him for his contributions to the society. Quite simply, he was the engine behind the society's formation - putting into reality the vision of our adviser Prof Au Eong Kah Guan, who first mooted the idea of setting up a macular degeneration support group in Singapore.

Sam gathered a team, courted sponsors to raise funds and drummed up the publicity to build awareness for macular degeneration and MDS. The 63-year-old even learnt how to set up a website from scratch in order to give the society a much-needed platform online.

Unknown to many, the grandfather of five often paid out of his own pocket to fund the society's activities and operations.

We look forward to his continued contributions to MDS as an Exco member and thank him, once again, for his hard work and dedication over the last two years.

Please click here to read the full bio of the Exco members.

Wednesday, 20 August 2008

The Last Lecture

Professor Randy Pausch may not suffer from macular degeneration, but his words, experiences and most of all, his life, is an inspiration to all - regardless of your medical condition. He has earned international fame for his "Last Lecture", which you can view below.

On July 25, at the age of 47, he died of pancreatic cancer. Before death, he said something which is a good motto for all of us - "You cannot change the cards you are dealt - just how you play the hand."



Wednesday, 13 August 2008

Do you have early treatment advice?

By Lim Kim Lan
An MDS member
Has anyone been given advice from an opthalmologist about early treatment regimes apart from not straining the eyes, taking nutritious food for eyes, etc? In my own experience, I would consider myself fully predisposed to MD since one of my eyes has been diagnosed with Myopic MD.
Yet no one (I have visited 3 different prominent specialists) has offered me any "early treatment regiment" so as to arrest MD developing in my remaining myopic eye (not yet affected by MD). All have just dismissed me with the info that they "can't do anything since yours is a "MYOPIC MD".
They merely prescribed some over-the- counter-eye drops for dry eyes and invited me to come back when when my eyes deteriorate!
Would love to hear from anyone with other experiences. Thank you.
Lim Kim Lan

Wednesday, 6 August 2008

Stem cells the answer?

Check out this informative video on how stem cells could be the answer to cure macular degeneration.